SATO RYO

Profile Information

Affiliation: National Institutes of Health

Degree: 医学博士(慶應義塾大学)

J-GLOBAL ID: 201701016051796432
researchmap Member ID: 7000021453

Research Areas

Life sciences / Respiratory medicine /

Papers

Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer

Kosuke Imamura, Yusuke Tomita, Ryo Sato, Tokunori Ikeda, Shinji Iyama, Takayuki Jodai, Misako Takahashi, Akira Takaki, Kimitaka Akaike, Shohei Hamada …

International Journal of Molecular Sciences, 23(22) 13723-13723, Nov 8, 2022
TGF-β signaling activated by cancer-associated fibroblasts determines the histological signature of lung adenocarcinoma

Ryo Sato, Kosuke Imamura, Takashi Semba, Yusuke Tomita, Sho Saeki, Koei Ikeda, Yoshihiro Komohara, Makoto Suzuki, Takuro Sakagami, Hideyuki Saya …

Cancer Research, canres.3941.2020-canres.3941.2020, Jul 21, 2021
Heterogeneous tumor-immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti-PD-L1 antibody therapy.

Shinya Sakata, Kosuke Imamura, Yuka Tajima, Yuiko Masuda, Ryo Sato, Chieko Yoshida, Shinichiro Okamoto, Sho Saeki, Yusuke Tomita, Takuro Sakagami

Thoracic cancer, 12(3) 397-401, Feb, 2021
Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with ALK Rearrangement-Positive Large Cell Neuroendocrine Carcinoma

Takahiro Tashiro, Kosuke Imamura, Yusuke Tomita, Daisuke Tamanoi, Akira Takaki, Kazuaki Sugahara, Ryo Sato, Koichi Saruwatari, Shinya Sakata, Megumi Inaba …

International Journal of Molecular Sciences, 21(24) 9705-9705, Dec 19, 2020
Association between HLA gene polymorphisms and mortality of COVID‐19: An in silico analysis

Yusuke Tomita, Tokunori Ikeda, Ryo Sato, Takuro Sakagami

Immunity, Inflammation and Disease, Oct 13, 2020
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: in silico analyses and a hypothesis

Yusuke Tomita, Ryo Sato, Tokunori Ikeda, Takuro Sakagami

Vaccine, Aug, 2020 Peer-reviewed
Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer.

Yusuke Tomita, Tokunori Ikeda, Shinya Sakata, Koichi Saruwatari, Ryo Sato, Shinji Iyama, Takayuki Jodai, Kimitaka Akaike, Shiho Ishizuka, Sho Saeki …

Cancer immunology research, 8(10) 1236-1242, Jul 14, 2020 Peer-reviewed
Non-small-cell Lung Cancer with Severe Skin Manifestations Related to Radiation Recall Dermatitis after Atezolizumab Treatment: A Case Report.

Kei Nakashima, Koichi Saruwatari, Ryo Sato, Kosuke Imamura, Ikko Kajihara, Satoshi Fukusima, Tetsuo Saito, Shiho Ishizuka, Daisuke Tamanoi, Takayuki Jodai …

Internal medicine (Tokyo, Japan), Feb 12, 2020 Peer-reviewed
Small Cell Lung Cancer Derived from Adenocarcinoma with Mutant Epidermal Growth Factor Receptor Provides a Signature of Transcriptional Alteration in Tumor Cells.

Tenjin Y, Nakamura K, Ishizuka S, Saruwatari K, Sato R, Tomita Y, Saeki S, Ichiyasu H, Fujii K, Ito T …

Internal medicine (Tokyo, Japan), 58(22) 3261-3265, Nov, 2019 Peer-reviewed
Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies.

Sato R, Imamura K, Sakata S, Ikeda T, Horio Y, Iyama S, Akaike K, Hamada S, Jodai T, Nakashima K …

Journal of clinical medicine, 8(6), May, 2019 Peer-reviewed
The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients.

Saruwatari K, Sato R, Nakane S, Sakata S, Takamatsu K, Jodai T, Mito R, Horio Y, Saeki S, Tomita Y …

Cancers, 11(2), Jan, 2019 Peer-reviewed
Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.

Akaike K, Saruwatari K, Okabayashi H, Hamada S, Jodai Y, Jodai T, Sakata S, Iyama S, Sato R, Iriki T …

Anticancer research, 38(11) 6543-6550, Nov, 2018 Peer-reviewed
227

A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.

Jodai T, Yoshida C, Sato R, Kakiuchi Y, Sato N, Iyama S, Kimura T, Saruwatari K, Saeki S, Ichiyasu H …

Immunity, Inflammation and Disease, Nov, 2018 Peer-reviewed
32

Trousseau's syndrome triggered by an immune checkpoint blockade in a non-small cell lung cancer patient.

Yuko Horio, Koutaro Takamatsu, Daisuke Tamanoi, Ryo Sato, Koichi Saruwatari, Tokunori Ikeda, Shunya Nakane, Makoto Nakajima, Sho Saeki, Hidenori Ichiyasu …

European journal of immunology, 48(10) 1764-1767, Oct, 2018 Peer-reviewed
オシメルチニブが奏効したT790M陽性肺多形癌の症例

城臺孝之, 佐伯祥, 木村俊貴, 坂本安見子, 坂田晋也, 佐藤亮, 猪山慎治, 入来豊久, 猿渡功一, 冨田雄介 …

肺癌, 58(4) 307-307, Aug, 2018
171

Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma

Shinya Sakata, Sho Saeki, Ryo Sato, Shiho Ishizuka, Jiichiro Sasaki, Kazuhiko Fujii

Respiratory Investigation, 55(6) 372-375, Nov 1, 2017 Peer-reviewed
Association of the bevacizumab pharmacokinetics with efficacy and toxicity in advanced non-small cell lung cancer

Megumi Inaba, Sho Saeki, Jiichiro Sasaki, Shinya Sakata, Ryo Sato, Koichi Saruwatari, Hiroto Kishi, Shinji Fujii, Akinobu Hamada, Hirotsugu Kohrogi

ANNALS OF ONCOLOGY, 28 77-77, Oct, 2017 Peer-reviewed
138

RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis

Ryo Sato, Teppei Nakano, Mari Hosonaga, Oltea Sampetrean, Ritsuko Harigai, Takashi Sasaki, Ikuko Koya, Hideyuki Okano, Jun Kudoh, Hideyuki Saya …

BIOMED RESEARCH INTERNATIONAL, 8032910, 2017 Peer-reviewedInvited
149

Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets

Ryo Sato, Takashi Semba, Hideyuki Saya, Yoshimi Arima

STEM CELLS, 34(8) 1997-2007, Aug, 2016 Peer-reviewedInvited
Dose Escalation and Pharmacokinetic Study of Carboplatin plus Pernetrexed for Elderly Patients with Advanced Nonsquamous Non-Small-Cell Lung Cancer: Kumamoto Thoracic Oncology Study Group Trial 1002

Shinya Sakata, Jiichiro Sasaki, Sho Saeki, Akinobu Hamada, Hiroto Kishi, Kazuyoshi Nakamura, Hideyuki Tanaka, Daisuke Notsute, Ryo Sato, Koichi Saruwatari …

ONCOLOGY, 88(4) 201-207, 2015 Peer-reviewed

Misc.

無症候性抗アセチルコリンレセプター抗体陽性非小細胞肺癌に対してニボルマブ療法を行い、完全奏効に至った1例

猿渡功一, 冨田雄介, 佐藤亮, 佐伯祥, 一安秀範, 藤井一彦, 坂上拓郎, 高松孝太郎, 中根俊成

肺癌, 59(3) 299-299, Jun, 2019
無症候性抗アセチルコリンレセプター抗体陽性非小細胞肺癌に対してニボルマブ療法を行い、完全奏効に至った1例

猿渡功一, 冨田雄介, 佐藤亮, 佐伯祥, 一安秀範, 藤井一彦, 坂上拓郎, 高松孝太郎, 中根俊成

肺癌, 59(3) 299-299, Jun, 2019
オシメルチニブが奏効したT790M陽性肺多形癌の症例

城臺孝之, 佐伯祥, 木村俊貴, 坂本安見子, 坂田晋也, 佐藤亮, 猪山慎治, 入来豊久, 猿渡功一, 冨田雄介 …

肺癌, 58(4) 307-307, Aug, 2018
ステロイドパルスが奏効したtype B1胸腺腫の1例

坂本安見子, 佐伯祥, 城臺孝之, 猪山慎治, 坂田晋也, 佐藤亮, 入來豊久, 猿渡功一, 冨田雄介, 中村和芳 …

肺癌, 58(4) 321-321, Aug, 2018
ステロイドパルスが奏効したtype B1胸腺腫の1例

坂本安見子, 佐伯祥, 城臺孝之, 猪山慎治, 坂田晋也, 佐藤亮, 入來豊久, 猿渡功一, 冨田雄介, 中村和芳 …

肺癌, 58(4) 321-321, Aug, 2018
進行非小細胞肺癌に対するニボルマブの治療効果と免疫関連有害事象の検討

後藤由比古, 猿渡功一, 坂本安見子, 城臺孝之, 坂田晋也, 佐藤亮, 猪山慎治, 冨田雄介, 佐伯祥, 中村和芳 …

日本呼吸器学会誌, 7(増刊) 246-246, Mar, 2018
小細胞肺癌の治療アウトカムに与える間質性肺疾患の影響

赤池公孝, 猿渡功一, 坂本安見子, 城臺孝之, 岡林比呂子, 坂田晋也, 濱田昌平, 猪山慎治, 佐藤亮, 入來豊久 …

日本呼吸器学会誌, 7(増刊) 319-319, Mar, 2018
進行非小細胞肺癌に対するニボルマブの治療効果と免疫関連有害事象の検討

後藤由比古, 猿渡功一, 坂本安見子, 城臺孝之, 坂田晋也, 佐藤亮, 猪山慎治, 冨田雄介, 佐伯祥, 中村和芳 …

日本呼吸器学会誌, 7(増刊) 246-246, Mar, 2018
小細胞肺癌の治療アウトカムに与える間質性肺疾患の影響

赤池公孝, 猿渡功一, 坂本安見子, 城臺孝之, 岡林比呂子, 坂田晋也, 濱田昌平, 猪山慎治, 佐藤亮, 入來豊久 …

日本呼吸器学会誌, 7(増刊) 319-319, Mar, 2018
進行非小細胞肺癌患者におけるベバシズマブの薬物動態と有効性,安全性との相関解析:KTOSG1003study

稲葉恵, 稲葉恵, 佐伯祥, 佐伯祥, 佐々木治一郎, 佐々木治一郎, 坂田晋也, 坂田晋也, 佐藤亮, 佐藤亮 …

日本臨床腫瘍学会学術集会(CD-ROM), 15th ROMBUNNO.O1‐4‐4, 2017
Nivolumab治療患者での免疫関連有害事象に対する血液スクリーニング検査の臨床的意義

猿渡功一, 佐伯祥, 坂本安見子, 城臺孝之, 坂田晋也, 佐藤亮, 冨田雄介, 興梠博次

日本臨床腫瘍学会学術集会(CD-ROM), 15th ROMBUNNO.P1‐331, 2017
EpCAM positive lung cells are involved in organoid formation

Takashi Semba, Ryo Sato, Makoto Suzuki, Hideyuki Saya, Yoshimi Arima

CANCER RESEARCH, 76, Jul, 2016
The association between gastric Mucin 5AC (MUC5AC) expressions, transforming growth factor-beta (TGF-beta) signal, and histopathological phenotypes of lung cancer in xenograft models

Ryo Sato, Takashi Semba, Hirotsugu Kohrogi, Hideyuki Saya, Yoshimi Arima

CANCER RESEARCH, 76, Jul, 2016
高齢者進行非扁平上皮非小細胞肺癌に対するCarboplatin+Pemetrexed併用療法の多施設共同第I相試験(KTOSG1002)

岸裕人, 坂田晋也, 佐々木冶一郎, 濱田哲暢, 佐伯祥, 中村和芳, 野津手大輔, 佐藤亮, 入来豊久, 興梠博次

日本臨床腫瘍学会学術集会(CD-ROM), 12th ROMBUNNO.O3-6-1, 2014
高齢者進行非扁平上皮肺癌に対するCarboplatin+Pemetrexed併用療法の多施設共同第I相試験(KTOSG1002)

坂田晋也, 佐々木治一郎, 濱田哲暢, 佐伯祥, 岸裕人, 中村和芳, 野津手大輔, 佐藤亮, 入來豊久, 田中秀幸 …

肺癌, 53(5) 452-452, Oct, 2013
Monitoring plasma drug concentrations in lung cancer patients on hemodialysis after chemotherapy: Review of 14 cases in Japan, including our own "joint worked"

Yasumiko Sakamoto, Aiko Masunaga, Ryo Sato, Sho Saeki, Hidenori Ichiyasu, Ji-ichiro Sasaki, Akinobu Hamada, Hirotsugu Kohrogi

Annals of the Japanese Respiratory Society, 2(5) 573-577, 2013
Effectiveness and safety of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of mediastinal and hilar lymphoadenopathy

Yuuki Tenjin, Junji Hamamoto, Shinya Sakata, Ryo Sato, Sho Saeki, Hidenori Ichiyasu, Kazuhiko Fujii, Naoki Saita, Hirotsugu Kohrogi

EUROPEAN RESPIRATORY JOURNAL, 40, Sep, 2012
肺癌による心臓転移を来した二例

佐藤亮, 坂田晋也, 佐伯祥, 一安秀範, 藤井一彦, 税田直樹, 興梠博次

日本呼吸器学会誌, 1(増刊) 342-342, Mar, 2012
肺癌による心臓転移を来した二例の検討

坂田晋也, 佐藤亮, 佐伯祥, 一安秀範, 藤井一彦, 税田直樹, 興梠博次

日本内科学会雑誌, 101(Suppl.) 195-195, Feb, 2012
外来化学療法施行中の肺癌患者に終末期を見越したACP(Advance Care Planning)は可能か?

佐々木治一郎, 佐伯祥, 佐藤亮, 坂田晋也, 坂本安見子, 興梠博次

肺癌, 51(5) 408-408, Oct, 2011

Profile Information

Research Areas

Papers

Misc.

Menu

Coauthors